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Abstract 
 
Objectives: Pain is known to reduce quality of life. Concurrently, it is believed that 
orofacial pain reduces the oral health-related quality of life (OHRQoL). While the impact 
that painful temporomandibular disorders (TMD) have on OHRQoL has been well 
described, little has been reported about the impact of acute dental pain (ADP). Moreover, 
the impact of trigeminal neuralgia (TN) and persistent dentoalveolar pain disorder (PDAP) 
on OHRQoL has not been reported yet. The aim of this study was, therefore, to compare 
the OHRQoL impairment among four orofacial pain conditions, i.e., participant with TMD, 
ADP, TN, and PDAP and compare the results with people without orofacial pain.  
Methods: OHRQoL was measured using the OHIP-49 questionnaire, using a convenience 
sample of four orofacial pain conditions (pain groups with TMD (n=30), ADP (n=27), TN 
(n=21), PDAP (n=16)). To provide a frame of reference for pain-related OHRQoL 
impairment, we also included a group of pain-free control participants (n=20). The mean 
OHIP-49 summary score, with its 95% confidence interval (95% CI), described the level 
of impact. The differences in mean values across the four pain conditions were analyzed 
using Analysis of Variance (ANOVA). The second part of the analysis was performed by 
comparing the OHIP-49 mean score of each condition and the OHIP mean score of the 
control group using Student's two sample t-test. Finally the absolute score differences 
between groups were judged according to: the Minimal Important Difference (MID) and 
the Effect sizes (ES). 
Results: OHRQoL was measured using OHIP-49 in a convenience sample of four 
conditions (patient groups with orofacial pain; TMD (n=30), acute dental pain (n=27), TN 
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(n=21), PDAP (n=16)). Our results showed significant impairment in the OHRQoL for the 
four conditions compared to the control group. The mean OHIP-49 score (95% CI) was 
60.8 (48-74) for TMD, 61 (48-74) for ADP, 58 (41-75) for TN, and 66 (46-86) for PDAP. 
For comparison purposes, the mean OHIP-49 score (95% CI) was 8 (3-13) for the pain free 
group. The difference was statistically significant and clinically relevant between pain 
groups and the control group (all comparisons: P<0.001). Each of the four orofacial pain 
conditions had similar levels of impact on the OHRQoL when compared to each other. 
Using the Minimum Important Deference (MID) there was a clinical significance between 
chronic conditions (TMD, TN, PDAP) and the ADP (11 (-6 to 28), 8.4 (-11 to 28), and 17(-
4 to 37)) respectively, also a clinical significance between the four orofacial conditions and 
the control group was detected. A moderate effect size was detected between participants 
with PDAP and ADP (ES=0.5, 95%CI (-0.1 to 1.1)).  
Conclusion: Our data supported the hypothesis that orofacial pain conditions have a 
substantial impact and adversely affect the quality of life of participants with four orofacial 
pain conditions as compared to those with no pain. 
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1. Introduction: 
 Pain in the orofacial region is a common problem with estimates suggesting 28% 
of people suffer from such pains in the USA1. The most common reason for pain in the 
orofacial region is acute dental pain ADP, which involves inflammation of the pulp and/or 
periodontium2. It is estimated to affect 12% of the American population, affecting males 
and females equally1. Another common type is pain associated with temporomandibular 
disorders (TMD), which is defined as "a group of conditions that cause pain and 
dysfunction in the jaw joint and the muscles that control jaw movement”3. It is estimated 
to affect between 5 to 12% of the U.S. population and believed to be the second most 
common musculoskeletal pain conditions after chronic low back pain, with an annual cost 
estimated at $4 billion4. It affects women 3 times more than men5 and occurs most often 
during the menstrual years, between 18 and 44 years of age6. A rare type of orofacial pain 
is trigeminal neuralgia (TN), which is defined as "sudden recurrent, severe pain in the 
distribution of one or more of the branches of the fifth cranial nerve7. It is estimated to have 
a prevalence of 0.01 to 0.02%, affecting three women to every two men, and with a typical 
onset occurring after the age of 60 years old8. Another orofacial pain condition is persistent 
dentoalveolar pain disorder (PDAP), which is defined as a persistent pain present in the 
dentoalveolar region that is not caused by dental pathology or referred from another 
region9. It is estimated to occur in 1.6% of all patients who received root canal therapy10, 
affecting females three to eight times more often than males, and has been reported to have 
an average onset between the ages of 40 and 50 years old9. 
 Pain in general is known to negatively impact the person experiencing it, affecting 
social functioning, physical functioning, and psychological well being11. Global 
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measurements of these impacts are commonly captured using quality of life instruments12. 
Orofacial pains are also known to have a negative impact on the person experiencing it and 
oral health-related quality of life (OHRQoL) is a well-acknowledged method for measuring 
this impact13 and the most widely used12. There are many instruments have been developed 
to measure the construct of OHRQoL (Table 1)14, with the most commonly used 
comprehensive instrument being 49 item Oral Health Impact Profile (OHIP-49)15. This 
instrument is a problem index, meaning higher scores representing high levels of oral 
health impairment, with the studies reporting general population having scores ranging 
from 9.7 to 17.116,17,18 and a 6 point different being considered statistically significant19. 
 Orofacial pains are known to exert a considerable burden on the society. TMD 
exerts a considerable burden on the people experiencing it with increased lost workdays 
and the use of the health care20. Multiple studies have used OHIP-49 to measure the amount 
of impairment that TMD has on participants, with those studies reporting a ranged of 42.9 
up to 60.6 OHIP-49 points16, 17, 18, 21. The impact of ADP on the oral health related quality 
of life was measured using the OHIP-49 for the measuring the responsiveness of the 
Croatian version and it was found to be elevated with 108.48 mean OHIP score22, similar 
results were found in a study done in Canada were a 72.7 OHIP mean score was detected 
using 17 items of the OHIP-49 version23. No studies have been found to measure the impact 
TN has on OHRQoL using OHIP-49 but the impact of TN on general health status has been 
measured using the modified Short Form Brief Pain Inventory (mBPI-SF) and EuroQol 
(EQ-5D) survey. This research found employment was affected in 34% of participants with 
TN and 33% of the participants reported the use of antidepressants, anxiolytic and/or sleep 
medications24. Little is known about on the impact of PDAP on the people experiencing 
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it25 and a search of the literature did not reveal any reports measuring this impact using a 
standard construct of OHRQoL, such as OHIP-49.  
Given that considerable information is known about the OHRQoL, as measured by 
OHIP-49, with common orofacial pains, namely TMD and to some degree ADP, the use 
of this metric allows for comparison of these conditions with other painful orofacial 
conditions, namely TN and PDAP. Obtaining this comparison is helpful in understanding 
the burden being experienced by those suffering from the less common orofacial pain 
conditions. Therefore, we sought to measure the impact various orofacial pain conditions 
have on the individuals experiencing using a standardized measure to characterized this 
impact and allow for comparisons between different orofacial pain conditions.  
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2. Specific Aims: 
Using OHIP-49 we assessed the impact on the OHRQoL of four orofacial pain 
conditions (TMD, ADP, TN, and PDAP) on those experiencing them, with a 
comparison with a group of pain-free participants to serve as controls.  
Hypotheses: 
1. The mean OHIP-49 score for participants with TN and PDAP is 
not different from the mean OHIP-49 score of either participants 
with TMD or ADP. 
2. The mean OHIP-49 score for participants with TMD, PDAP, TMD, 
and ADP is higher than the mean OHIP-49 score of pain-free 
controls, as assessed by minimum importance difference (MIP) 
and effect size (ES). 
3. There is no difference in the specific item prevalence between 
participants with TMD, ADP, TN and PDAP. 
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3. Material and Methods: 
3.1 Study design: 
This study was cross-sectional in nature and was comprised of a convenience 
sample for each of the five difference groups, four groups of participants with different 
orofacial pain conditions and one group of pain-free controls. This research was part of a 
parent study designed to identify question items to be used for the development of a 
screening questionnaire for PDAP. This parent study included six questionnaires, of which 
OHIP-49 was one, and these questionnaires were presented in random order to each 
participant. The local research ethics committee at the University of Minnesota approved 
this study and all participants provided written informed consent prior to their participation.  
3.2. Settings: 
Participants were given instructions and explanations of the different aspects and 
questions contained in the questionnaire, which was generally completed at the clinic in 
the presence of one of the investigators. For logistical and practical reasons, few 
participants filled the questionnaires at home and if they encountered difficulty in 
understanding the text, the research investigator helped the participants understanding the 
questions at the next visit. Participants were paid a nominal compensation of $20 for their 
time in participating in this research. 
Each participant was given a number of questionnaires presented in random order 
(Table 2). The TMD, TN, and PDAP participants were mostly recruited by faculty at the 
TMD, Orofacial Pain, and Dental Sleep Medicine Clinic at the University of Minnesota. 
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Two of the PDAP participants were recruited by Dr. Cory Herman at the Minnesota Head 
and Neck Clinic. All participants with ADP diagnosis were recruited by Dr. Alan Law at 
The Dental Specialists clinic in Lake Elmo, Minnesota. All dentists recruiting participants 
were board certified in their respective disciplines. Pain-free controls were recruited from 
the School of Dentistry clinics by approaching pain-free patients, relatives and friends 
accompanying the participants, and people in the University community. 
3.3 Participant selection criteria: 
The following criteria were used to select participants for this study: 
Inclusion Criteria: 
• Age, 18 years old and older.  
• Participants were fully able to cooperate and respond to the questions. 
• ADP sample: participants diagnosed with irreversible pulpitis and/ or 
symptomatic apical periodontitis, following the diagnostic criteria by 
Gutmann, 2009 26. 
• TMD pain sample: participants with TMD diagnosis including myalgia, 
myofacial pain, arthralgia or headaches attributed to TMD following the 
DC/TMD diagnostic criteria27. 
• For TN participants the diagnosis was performed following the ICHD-II 
Diagnostic Criteria for Classical Trigeminal Neuralgia28. 
• Participants with persistent dentoalveolar pain disorder the diagnosis was 
made by experienced board certified clinician following the diagnostic 
criteria Nixdorf et al. in 20129.( Figure 1) 
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• Pain free had to response "NO" to the following question, “Have you had 
any pain in your face, mouth, teeth, jaw or ears, in the last 3 month", and 
with no treatment seeking behavior. As well, they had to have no history of 
TMD problems, clenching, or a higher degree of tooth wear and were fully 
able to cooperate and respond to the questions 
Exclusion Criteria: 
• A history of traumatic injuries to the orofacial region. 
• A major systemic illness related to altered pain sensitivity, such as 
fibromyalgia or other widespread bodily pain conditions. 
• A history of TMJ surgery or inter-articular steroid injection. 
• Unable to give informed consent. 
• Previously enrolled in this study. 
3.4. Questionnaire: 
 OHRQoL was measured using the oral health impact profile (OHIP-49); it is 
considered one of highly used tools in evaluating the OHRQoL17. An example of an OHIP 
statement is "Have you found it difficult to relax because of problems with your teeth, 
mouth or dentures?" responses were made on a scale 0 (never), 1 (hardly ever), 2 
(occasionally), 3 (fairly often), 4 (very often). OHRQoL impairment was characterized by 
the OHIP-49 summary score, which is the simple sum of all 49-item responses and can 
range from 0 to 196 OHIP units (with 196 representing a participant answering ‘‘very 
often’’ to all 49 items). A zero sum score of the 49 item indicate a non-existing impairment 
on the OHRQoL and the higher the OHIP summary score the higher is the impairment of 
OHRQoL.  
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3.5. Data management and analyses: 
 Data were managed using the spreadsheet software Microsoft Excel (Microsoft 
Excel 2010 for PC: Microsoft Corporation) and all analyses were performed using the 
statistical software package STATA release 9 (Stata Corp LP, College Station, TX). 
 The four condition’s OHIP49 mean values (including their 95% confidence 
intervals) were compared with controls to assess the condition-specific impact on 
OHRQoL. They were also compared with each other to assess whether OHRQoL 
impairment is different across orofacial pain conditions. Differences in mean values across 
the four pain conditions were analyzed using Analysis of Variance (ANOVA) possibly 
followed up by t-tests in case the ANOVA omnibus test is statistically significant. The 
magnitude of differences was assessed with two approaches. Absolute score differences 
between groups were judged according to the Minimal Important Difference (MID) for 
OHIP-49 scores29. The MID is defined as “the smallest difference in score in the domain 
of interest which patients perceive as beneficial and which would mandate, in the absence 
of troublesome side effects and excessive cost, a change in the patient’s management”19. 
Differences between groups were also expressed in a relative metric using effect sizes (ES) 
which we calculated as standardized difference between two means according to Cohen. 
Cohen’s d is the difference between two means divided by a standard deviation for the 
data, and guidelines exist judging the magnitude of an ES of 0.2 as “small”, an ES of 0.5 
is “medium” effect, and an ES of 0.8 is a “large.”30. In addition to comparing OHIP-49 
mean values across groups, the distribution of scores for all four orofacial pain conditions 
was presented as empirical cumulative distribution functions to assess whether OHRQoL 
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impairment varies across groups. We aimed to visually compare the four score distributions 
for substantial differences and to compare key quantiles such as the median. 
The second part of the analysis we computed the summary scores of the ordinal responses 
and the numerical frequencies for each participant and assessed whether the ordinal OHIP 
mean summary scores different significantly from that for the control group using Student's 
two sample t-test. After assessment of the magnitude of scores differences, we 
analyzed differences in score means statistically with an Analysis of Variance 
(ANOVA), possibly followed up by t-tests for pairwise comparisons in case the 
ANOVA omnibus test is statistically significant. A regression analysis with OHIP-49 
scores as dependent variable and the 4 pain conditions as indicator (independent) 
variables, controlled for age (median split into lower versus higher age), education 
(level 1= less than High School, 2= High school, 3= Some college, versus 4= college 
degree and 5= Advanced or graduate degree), and sex, allowed the assessment how 
large OHIP-49 differences between pain groups are when sociodemographic factors 
are controlled. These adjusted groups difference were again compared to the OHIP-
49 MID29. 
As the last step of our analytic approach, for exploratory purposes, we 
computed differences in item prevalence for OHIP problems occurring “fairly often” 
or “very often” for all 6 pairwise contrasts of the four pain conditions. We calculated 
6(number of comparisons)*49(number of OHIP items)=294 differences with their 
confidence intervals to explore which items differed the most between group. 
However, only the differences exceeding 30% as the absolute difference between any 
two pain conditions were presented to gain insight about the magnitude of item 
9 
 
prevalence differences, which problem areas are affected the most, and which group 
contrasts are most prevalent.  
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4. Results: 
 A total number of 114 participants were recruited for the study, of which 30 were 
TMD participants, 27 ADP participants, 21 TN participants, 16 PDAP participants, and 20 
pain free controls. All individual questions of the OHIP-49 questionnaire were answered 
by each participant resulting in no missing responses. 
 4.1. Participants’ characteristics:  
Basic demographic data and clinical data are presented in (Table 3). The mean age of cases 
was 49.6 years. The majority of participants were female (73%), white (90%), and (34%) 
had graduate degree. Forty-seven percent of participants reported an annual household 
income equal or greater than $50,000 per year. The most significant difference between 
groups was the level of education; being higher in participants with PDAP, 44% had an 
advanced or graduate degree. Compared to controls, orofacial pain participants were older, 
more often women and less educated; however, in general, these differences were not large. 
Among orofacial pain conditions, sociodemographic differences were less pronounced. 
4.2. Magnitude and statistical significance of OHIP-49 summary scores differences 
inter pain conditions and between pain conditions and controls: 
All OHIP-49 differences between each of the four pain conditions and the control 
group were statistically significant (all comparisons: p<0.001). When OHIP-49 means 
were tested across pain conditions with an ANOVA across the four pain conditions, the 
omnibus test was not statistically significant (p=0.43) and excluded any statistically 
significant differences across the four groups. 
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 As expected, the four pain conditions were remarkably different from control 
participants in terms of OHRQoL impairment. The conditions’ differences (compared to 
controls) were at least 41 OHIP score points and exceeded by far the MID of 6 OHIP points 
(Table 4). Among pain conditions, the chronic types (TMD, TN, PDAP) had at least 8 
OHIP-49 points higher OHRQoL levels than the acute tooth pain, again exceeding the 
MID. The differences are not statistically significant among pain conditions using analysis 
of variance (Figure 2); however, a considerable uncertainly around OHIP differences were 
observed. Using standardized differences, i.e., effect sizes, to compare groups, large effect 
with at least 1.8 were observed and exceeded by far the 0.8 threshold for large effects. 
Again, as for the absolute differences, confidence intervals were wide.  
 Among the four pain conditions, differences were not so large with only 4 of the 6 
pairwise group differences exceeding the MID. In particular, the chronic pains (TMD, TN, 
PDAP) seemed to form a cluster of conditions that was different compared to the acute 
tooth pain. All differences included in the lower limit of the 95% confidence interval the 
MID. The ES comparing the groups were medium (N=1), small (N=3), or no effect (N=2), 
supporting a pattern of small differences among groups that appeared despite wide 
confidence intervals around point estimates. This pattern was also observed when the entire 
distribution of scores for the 4 pain conditions was compared (Figure 3). Median and other 
quantiles of score distributions were similar across conditions. No pattern was apparent 
that a particular condition’s score distribution had always lower (or higher) quantiles than 
other distributions.  
 Furthermore, in a regression analysis comparing the four pain conditions (base 
category: PDAP) adjusted for age, gender, and education in their influence on OHIP-49, 
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none of the pain conditions was statistically different (as previously observed) but only 
ADP exceeded with a 15 OHIP-49 the MID of 6 points. This means, in terms of OHRQoL 
magnitude, differences among chronic pain conditions were all smaller than the MID and 
each chronic condition had a larger OHRQoL influence compared with ADP as judged by 
the MID (Table 5). 
4.3. Comparing OHIP item prevalences among the four pain conditions:  
 Among the 294 calculated pairwise differences of item prevalences were 16 
differences that were greater than 30% (Table 6). Except for two items “Worried by dental 
problem” (appeared two times) and “difficulty chewing”, all items described various aspect 
of dental, oral, and orofacial pain. The item with the largest difference (“headaches") had 
a rather low prevalence (less than 10%) in TN and ADP participants and a substantial 
prevalence in TMD participants produced the largest contrast between item prevalences. 
“Sore jaw” was the item that appeared the most in these comparisons with 3 occurrences. 
It seemed to differentiate the best across pain conditions with a high prevalence in TMD 
(67%) and lower prevalence in PDAP (19%), ADP (22%) and in TN (24%) participants. 
TMD was present the most with 11 occurrences and ADP was present the least with 5 
occurrences, leading to the impression that TMD had somewhat higher impact, followed 
by PDAP and TN and ADP last. However, overall, this pattern was not very strong based 
on this exploratory data interpretation.   
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5. Discussion: 
 The ability of dental clinicians and researchers to estimate oral health and to 
promote for dental care has been hindered by a limitation in measurements of the level 
of dysfunction, discomfort, and disability associated with oral conditions31. 
Therefore, we used the Oral Health Impact Profile 49 (OHIP-49), which is a 
standardized and internationally satisfactory measure for the evaluation of OHRQoL, 
to charactarize the level of impairment of individuals affected by four different 
orofacial pain conditions. Built on Locker’s conceptual model of oral health15, initially 
OHIP-49 items were grouped into 7 domains: Functional Limitation, Physical Pain, 
Psychological Discomfort, Physical Disability, Psychological Disability, Social Disability, 
and Handicap. The Dimensions of OHRQoL Project (DOQ) suggested based on 
exploratory factor analytic results in N=5,173 international participants and confirmatory 
factor analytic results in N=5,022 that Oral Function, Orofacial Pain, Orofacial 
Appearance, and Psychosocial Impact are four major aspects of patient-perceived 
OHRQoL32, 33. However, the DOQ Project also cautioned the use of dimensions scores 
because they need more methodological work and recommended that OHRQoL measured 
with OHIP can also be sufficiently described with one, overall summary score33. Therefore, 
the simple sum of the 49 OHIP items was used as our OHRQoL measure. 
 This study is the first to investigate the effect of TN and PDAP on the perceived 
OHRQoL of these participants’ using OHIP-49. The OHIP summary scores indicated a 
lower OHRQoL in PDAP participants (mean sum score: 66.2; 95% CI: 46.3-86.0) then 
came next participants with TMD (mean sum score: 60.8; 95% CI: 47.7-74), participants 
with TN (mean sum score: 57.9; 95% CI: 40.9-75), and last participants with ADP (mean 
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sum score: 49.5; 95% CI: 38.4-60.7). However, the difference was statistically 
insignificant. Nonetheless, following the use of effect sizes for characterizing the group 
differences there was a moderate effect size between the ADP and PDAP groups. The 
distribution of the four orofacial pain participants’ summary scores was yet markedly 
different from the general population (mean sum score: 8.35; 95% CI: 3.3-13.4), indicating 
that general population participants represented the lowest impact of OHRQoL among 
groups. In this study, as expected, participants who were seeking treatment had 
significantly more issues, as defined by OHIP-49 mean score, than pain free participants. 
Among the four conditions female prevalence was noted. The chronic pain conditions 
(TMD, TN, PDAP) seemed to cluster together in the magnitude of their impact and 
were different from ADP when compared in terms of absolute OHIP-49 differences 
using the instrument’s Minimal Important Difference as benchmark or in terms of 
relative (standardized) OHIP-49 differences expressed as effect sizes and using 
widely applied guidelines for interpretation. The difference may be related to the 
chronicity of the pain, with ADP being acute and being less troubling than TMD, TN, 
and PDAP.  
 The impact of TMD have been intensely studied using OHIP instruments, therefore, 
TMD has a great reference value in our study since much has been known about its 
impact17. There is a great interest in studying OHRQoL for these participants that has led 
to the development of a condition-specific OHIP34. Our results are in line with previous 
studies that measured the OHRQoL in participants with TMD diagnosis. The impact of 
TMD, in particular painful TMD, on OHRQoL is well documented by a meta-analysis35 
and we are able to compare our results with previous work using the OHIP-49. Among the 
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studies that have been performed to measure the OHRQoL in TMD participants is a study 
using OHIP-G, the German translation of the OHIP-49, the OHRQoL was noticeably 
affected in the TMD participants with a mean OHIP score of 42.9 compared to the general 
population17. Moreover, participants with all diagnosis, using the RDC/TMD, had a similar 
impact except participants with disc displacement with reduction with an OHIP score of 
(32.8). That justify why we have not excluded participants with disc displacement with 
reduction without TMD pain from the control group. The OHIP mean value was almost 
identical to results found in a British group of TMD participants, this study attempted to 
rank the OHIP items by prevalence for participants with TMD using the OHIP-49. The 
results revealed an impaired oral health quality of life, with mean OHIP-49 score for 
participants with TMD 60.6 suggesting impairment in OHRQoL18. Moreover, a 
relationship between deteriorated general health and TMD has been recognized and 
numerous studies have detected coexistence of TMD symptoms and other painful 
conditions in the same individual36wich indicate the great impact of TMD on participants’ 
lifes. Furthermore, TMD was not only used in measuring its effect on the OHRQoL, but it 
has been also used in the development and validation of long and short editions of the 
OHIP. The result of our study also is consistent with these other studies16,13 
 For the ADP, fewer studies are available that describe the impact of this condition 
on OHRQoL. In a study performed to develop a Croatian version of OHIP-49, a group of 
participants with ADP were used to measure the responsiveness of the profile22. The OHIP 
score of those groups of participants was elevated, at 108.5, for the OHIP summary score 
before treatment. Dugas et. al. investigated the effect of dental pain on the OHRQoL using 
17 items from the OHIP-49, and compared the change in the OHIP score following 
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endodontic treatment the result for this study revealed an impaired OHRQoL before 
treatment and followed by a significant improvement after endodontic treatment23. In 
longitudinal prospective study that measured the OHRQoL of participants with ADP using 
the OHIP-14 before and after treatment it has been found that the OHIP-14 score have been 
elevated before endodontic treatment37. In another study that investigated the conformity 
between different pain scales, it has been found that the OHIP-14 of participants seeking 
emergency dental treatment for ADP was elevated indicating impaired OHRQoL38. It is 
difficult to compare our results with the above-mentioned two studies because one used 17 
item of the OHIP-4923 and the others37, 38 used OHIP-14 instead of OHIP-49, which is used 
in our study. However, in general both studies indicate impairment in the OHRQoL in 
participants suffering of ADP even though using different metric, which is consistent with 
our results. 
 Surprisingly, even though trigeminal neuralgia has been known to be one of the 
most painful conditions affecting the human being39, our results suggest participants 
suffering of TN had a similar OHIP score to those with other orofacial pain conditions. 
One reason for this is that OHIP-49 may not be sensitive to capturing this type of pain that 
is known to have pain-free intervals, and therefore may not be valid because they may not 
have had an attack in the last month. Another reason could have impacted the results is that 
some of the trigeminal neuralgia participants had treatment initiated and were experiencing 
considerable pain relief and some were not. Even so, this study demonstrated a significant 
burden related to trigeminal neuralgia and its effect on the quality of life, which is 
consistent with what has been reported in other studies. To illustrate this point, the overall 
burden of TN on participants using modified Short Form Brief Pain Inventory (mBPI-SF) 
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and EuroQol Survey found that more impairment occurred during severe pain and it mostly 
affected mood and the general activity of affected participants24. 
 Characterizing TN and PDAP participants with an OHRQoL measures is new. We 
did not find any literature that described the burden of these conditions using OHIP-49. 
The mean summary score of OHIP score for PDAP participants was elevated (66.2) 
reflecting an impaired quality of life and showed significant difference between the OHIP 
mean summary score between PDAP participants and normal control participants. There 
are no studies investigating the burden of PDAP on participants using OHIP-49, however, 
some studies investigated the burden of using other methods and revealed a significant 
psychological and social impact on PDAP participants25. In a longitudinal study that 
followed PDAP participants for seven years, results have shown that only one third of the 
PDAP participants report improvement in their symptoms40. That study indicated that 
participants with PDAP, unlike other orofacial pain conditions (TMD, ADP, TN), are not 
successfully managed leading to higher impact on their quality of life. Therefore, our 
results further suggest that research is needed to improve the management of patients with 
PDAP because their pain, which is similar to ADP in quality, has similar OHRQoL 
impairment. Thus, it appears that these patients continuously suffer for a “toothache” that 
is refractory to most treatments. 
 While we used a convenience sample of control participants, others used a random 
sample of the general population without an RDC/TMD diagnosis or with Helkimo 
Classification A0/D0, i.e., without (self-reported) symptoms or (clinical) sign according to 
the Helkimo Index41, to define their comparison participants for providing a framework 
about the magnitude of OHRQoL impairment16. However, our control group, while 
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methodologically inferior to a random sample, yielded a similar a mean OHIP-49 score of 
9.7 to these other studies16, 42. Moreover, a relationship between deteriorated general health 
and TMD has been recognized and numerous studies have detected coexistence of TMD 
symptoms and other painful conditions in the same individual36 wich indicate the great 
impact of TMD on patients’ lives. 
 Synthesizing our main findings with our exploratory analyses, we have some 
hypotheses why OHRQoL differences are not large among orofacial pain conditions. First, 
orofacial pain conditions are often co-morbid, that is pain conditions often coexist. For 
example, patients with PDAP often suffer from TMD43. As well, ADP patients also 
experience TMD pain44. Conversely, TMD can also sometimes be referred to the tooth 
area45. The co-existence of orofacial pain conditions, even if one condition is clinically 
dominating, would make pain impact across conditions more similar – a situation we 
observed. Second, report of dental, oral, and orofacial pain conditions cluster together. 
They form a “dimension” of OHRQoL and are an important and distinct area within the 
umbrella construct of OHRQoL. For example, the original 49-item OHIP suggested a 
dimension Physical Pain that contains tooth, gum, jaw and other pains items. Recently, the 
dimension of orofacial pain was empirically confirmed and was distinct from the other 
OHRQoL dimensions Oral Function, Orofacial Appearance, and Psychosocial Impact42. 
Likewise, more qualitative studies with experts assigning OHIP items to dimensions17, or 
experts studying the 14-item OHIP responses by U.K. and Australian general population 
participants. They studied whether the OHIP items fit into a conceptual OHRQoL model42 
(which also contains the dimension discomfort/pain) 15 led also support for a dimension 
pain in the stomatoganthic system. All these findings support that dental, oral, and orofacial 
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pain are an important component (dimension) how patients perceive their oral health and 
the several pains correlate and influence each other. 
 Limitations of the study: 
 One of the limitations of this study is that the study sample being small and there 
is substantial uncertainty indicated by the width of the confidence intervals. Therefore, 
mean values for individual orofacial pain conditions should be interpreted with caution. 
However, we believe that the overall pattern of OHRQoL across pain conditions, but in 
particular chronic conditions (TMD, TN, PDAP), is reasonably robust because several 
measures such as mean, median, and entire score distribution provided similar findings. In 
addition, results for TMD pain participants and ADP were compatible with the results 
observed by others. Results for TN and PDAP are new. For these two groups, it is often 
challenging to collect large samples because the prevalence of these conditions is 
substantially lower than TMD pain or ADP. For future studies a bigger study sample is 
recommended.  
 A second limitation is that some of the participants among the four orofacial 
conditions were engaged in care even though they were still symptomatic; we think they 
might have experienced some reduction in their symptom of pain and that could have 
affected the OHIP score. If participants were recruited as they first received the diagnosis 
and have not yet received any treatment that could have changed the results. In particular, 
TN group, where participants who received medical treatment for their complaint have not 
been excluded of the study, our results are not compatible with the fact that TN pain is 
among the worst.  
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 A third limitation is only the physical impact of TMD, TN and PDAP was 
considered. The specific impact of conditions such as depression and anxiety was not 
regarded. However, it is well documented that there is a relationship between these 
conditions and OHRQoL17; implying OHIP may be suitable to catch some of the impact of 
these conditions in a single measure16. Even though the psychological status of participants 
was not examined, this limitation is not of a great significance. OHIP-49 is thought to 
identify 3 out of 4 aspects of axis II (R) DC/TMD17; therefore, we expect that OHIP device 
has the property of measuring the psychological significance of other conditions, too. 
 For future studies a broader implication of OHIP could be used, such as 
investigating the clinical outcome, satisfaction, and quality of life in a longitudinal study. 
Moreover, a larger sample size and a more careful selection of the participants are 
recommended. 
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6. Conclusion: 
 Our data supported the hypothesis that orofacial pains have a substantial 
impact, negatively affecting the quality of life of participants with the four orofacial 
conditions compared to those with no pain. However, differences among the chronic 
orofacial pains are likely not substantial. There was some difference in the item 
prevalences between orofacial groups and all items seemed to describe various aspects 
of dental, oral and orofacial pain with TMD having the highest occurrence.  
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Tables: 
 
Table 1: Example of currently available Oral health measures 13 
 
 
 
 
 
 
 
Authors Name of Measure 
Cushing et al, 1986 Social Impacts of Dental Disease 
Atchison and Dolan, 1990 Geriatric Oral Health Assessment Index 
Strauss and Hunt, 1993 Dental Impact Profile 
Slade and Spencer, 1994 Oral Health Impact Profile 
Locker and Miller, 1994 Subjective Oral Health Status Indicators 
Leao and Sheiham, 1996 Dental Impact on Daily Living 
Adulyanon and Sheiham, 1997 Oral Impacts on Daily Performances 
McGrath and Bedi, 2000 OH-Qol UK 
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Table 2: Questionnaires were given to the participants 
  
Questionnaire 
1 
Questionnaire 
2 
Questionnaire 
3 
Questionnaire 
4 
Questionnaire  
5 
Questionnaire 
6 
New PDAP 
instrument 
(Items=14) 
Likert scale 
Generic 
Neuropathic 
instrument: 
S-LANSS 
(Items = 7) 
Converted to 
statements 
and use 
Likert scale 
Tooth pain 
instrument: 
(Pau et al 
2005) 
(Items=14) 
TMD 
screener: 
(Gonzalez et 
al 2011) 
(Items=6) 
OHIP 49 
(Slade and 
Spencer 
1994) 
(Items=49) 
Multidimensi
onal 
instrument: 
Hapak 
instrument 
(Hapak et al 
1994) 
(Items = 24) 
24 
 
  
Table 3: Sociodemographic and clinical characteristics for four orofacial pain 
conditions and control participants 
*Level of education 4-5: participants with collage, advanced or graduate degree. 
  
Characteristics TMD ADP TN PDAP Controls N=30 N=27 N=21 N=16 N=20 
Age [years] mean 
(SD) 
46 (17) 47 (12) 60 (18) 52 (14) 45 (14) 
Gender (Female %) 80 67 88 67 65 
Race (white %) 90 82 95 100 90 
Level 4-5 
*education % 
85 75 52 60 52 
OHIP-49 (SD) 66 (6) 50 (5) 58 (8) 66 (9) 8 (2) 
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Table 4: OHIP mean score differences and effect sizes for pairwise comparisons of 
four orofacial pain conditions (PDAP, TN, TMD, or ADP) versus control participants 
and the each conditions versus the three remaining condition   
 
 
 
 
 
  
 OHIP-49  score differences Effect sizes 
 PDAP TN TMD ADP PDAP TN TMD ADP 
 N=16 N=21 N=30 N=27 N=16 N=21 N=30 N=27 
 Mean (95% confidence interval) 
Pain condition 
vs. controls 
-57.8 
(-75.6 to -
40.1) 
-49.6 
(-67.3 to -
31.9) 
-52.5 
(-68.9 to -
36.1) 
-41.2 
(-54.6 to -
27.8) 
-2.2 
(-3.1 to -
1.4) 
-1.8 
(-2.5 to -
1.0) 
-1.9 
(-2.5 to -
1.2) 
-1.8 
(-2.5 to -
1.1) 
PDAP vs. other 
pain conditions - 
8.2 
(-17.0 to 
33.4) 
5.4 
(-17.1 to 
27.8) 
16.7 
(-3.6 to 
36.9) 
- 
0.2 
(-0.4 to 
0.9) 
0.1 
(-0.5 to 
0.8) 
0.5 
(-0.1 to 
1.1) 
TN vs. other 
pain conditions  - 
-2.9 
(-23.6 to 
17.8) 
8.4 
(-10.7 to 
27.5) 
 - 
-0.1 
(-0.6 to 
0.5) 
0.3 
(-0.3 to 
0.8) 
TMD vs. other 
pain 
conditions) 
  - 
11.3 
(-5.8 to 
28.4) 
  - 
0.4 
(-0.2 to 
0.9) 
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Table 5: Regression analysis, comparing the TN, TMD, and ADP against the base 
category PDAP, adjusted for age, gender and education 
OHIP-49 Coef Std. Err. t P>|t| [95% C.I] 
TMD -4.9 10.9 -0.45 0.7 -26.6 - 16.7 
ADP -14.6 11.3 -1.29 0.2 -37.1 - 7.9 
TN -4.3 11.7 -0.37 0.7 -27.5 - 18.9 
Age_2cat -5.3 7.7 0.69 0.5 -20.5 - 9.9 
Female 8.3 8.5 0.97 0.333 -8.7 - 25.3 
Educa_4or5 6.6 7.3 0.90 0.370 -7.96 - 21.1 
controls 62.6 19.1 3.28 0.001 24.69 - 100.6 
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 Table 6: Differences in prevalence greater than 30% for OHIP items mentioned 
“fairly often” or “very often” among possible 294 pairwise comparisons for six 
orofacial pain conditions and 49 OHIP items 
Item 
Pair of 
conditions 
Item 
prevalence  
condition 1 
Item 
prevalence  
condition 2 
Difference in prevalence 
(95% CI*) 
1 TMD- PDAP 0.25 0.57 0.32 (-0.59 to-0.04) 
10 PDAP-TN 0.81 0.33 0.48 (0.20 to 0.76) 
10 PDAP-ADP 0.81 0.41 0.41 (0.14 to 0.67) 
11 TMD- PDAP 0.19 0.67 0.48 (-0.73 to -0.22) 
11 TMD-ADP 0.67 0.22 0.44 (0.21 to 0.67) 
11 TMD-TN 0.24 0.67 0.43 (-0.68 to -0.18) 
12 TMD-TN 0.05 0.57 0.52 (-0.72 to -0.32) 
12 TMD-ADP 0.57 0.07 0.49 (0.29 to 0.70) 
12 TMD- PDAP 0.25 0.57 0.32 (-0.59 to-0.04) 
14 PDAP-TN 0.56 0.19 0.37 (0.08 to 0.67 
14 ADP-TN 0.19 0.52 0.33 (-0.58 to-0.08) 
15 PDAP-TN 0.50 0.10 0.40 (0.13 to 0.68 
15 PDAP-TMD 0.50 0.10 0.40 (0.13 to 0.67) 
17 PDAP-TMD 0.44 0.13 0.30 (0.03 to0.58)  
19 TMD-ADP 0.60 0.26 0.34 (0.10 to 0.58) 
19 TMD-TN 0.29 0.60 0.31 (-0.58 to-0.05) 
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Figures: 
 
 
 
Figure 1: Diagnostic Criteria for PDAP (Nixdorf et al, 2012) 
Criteria: 
1 persistent meaning pain present at least 8 h per day ≥15 days or more per month for ≥3 months 
during 
2 pain is defined as per IASP criteria (includes dysesthesia) 
3 localized meaning the maximum pain defined within an anatomical area 
4 extent of evaluation non-specified (dental, neurological examination +/−) imaging, such as 
intra-oral, CT and / or MRI). 
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Figure 2: Empirical cumulative distribution functions for OHIP-49 scores of four 
orofacial pain conditions 
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Figure 3: OHIP mean score in relation to four different Orofacial Pain conditions in 
compression with pain free control. Differences are not statistically significant among 
pain conditions in Analysis of Variance 
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